COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04751669

Teresa M Tomasa-Irriguible, MD-PhD

Not reported

2021-02-12

Completed

RCT

Randomized

Parallel

Blind label

single-center

Treatment

inclusion criteria: informed consent form signed. patients with symptoms compatible with covid-19: cough and fever who not fulfil criteria of hospitalization and will be in outpatient care. positive polymerase chain reaction (pcr) or transcription-mediated amplification (tma) test or rapid antigen test for severe acute respiratory syndrome corona virus-2 (sars-cov-2) or diagnostic test available. age ≥ 18 years availability to meet the requirements of the protocol.

intake of any micronutrient supplement during the month prior to inclusion. patients fulfilling hospitalization criteria. previous allergies to the micronutrient components and excipients. age ≥ 90 years with any comorbidity (diabetes, hypertension, obesity, heart disease, respiratory disease) participation in other research that requires experimental intervention (does not include observational studies) in the previous month before signing the informed consent form. detection by the researcher of lack of knowledge or willingness to participate and comply with all the requirements of the protocol. any other findings that at the discretion of the researcher may compromise protocol performance or significantly influence the interpretation or results of the effects of the nutritional supplement pregnancy or breastfeeding

2

Fundació Institut Germans Trias i Pujol

18

90

Spain

Mild disease at enrollment

1: Mild disease at enrollment

252

Incidence of Long Covid.;Need for hospital admission

None

Not reported

[{"arm_notes": "", "treatment_id": 803, "treatment_name": "Micronutrients", "treatment_type": "Nutrition", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]